Epidemiology Forecast on Sjogren’s Syndrome to 2029 – ResearchAndMarkets.com
The “Sjogren’s Syndrome – Epidemiology Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.
Sjogren’s syndrome (SS) is a chronic autoimmune disease, characterized by immune cells attacking and destroying the glands that produce tears and saliva (NIH, 2019). It results in two major clinical manifestations: keratoconjunctivitis sicca (dry eyes) and xerostomia (dry mouth), more broadly known as sicca syndrome (Arthritis Foundation, 2019). It can be classified into two types, primary and secondary SS. Primary SS (pSS) is seen in the absence of any other autoimmune disease (Salliot et al., 2007). Those most at risk of disease are women ages 40 and older (Johns Hopkins University, 2020).
Through an extensive literature review and analysis of recent and historical data, the publisher epidemiologists have provided the most reliable and up-to-date forecast for SS in the 7MM. The publisher epidemiologists performed a literature review, in both English and country-specific languages, to provide the most thorough search for SS data. The forecast provides detailed, clinically relevant segmentations of the SS population, with pSS prevalence, sSS prevalence, and ESSDAI proportions included in all markets.
The publisher epidemiologists have forecast the diagnosed prevalent cases of SS in the 7MM to increase from 1,630,861 in 2019, to 1,753,781 in 2029, …